Literature DB >> 17928361

ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site.

Sahil Adriouch1, Peter Bannas, Nicole Schwarz, Ralf Fliegert, Andreas H Guse, Michel Seman, Friedrich Haag, Friedrich Koch-Nolte.   

Abstract

ADP-ribosylation is a post-translational modification regulating protein function in which amino acid-specific ADP-ribosyltransferases (ARTs) transfer ADP-ribose from NAD onto specific target proteins. Attachment of the bulky ADP-ribose usually inactivates the target by sterically blocking its interaction with other proteins. P2X7, an ATP-gated ion channel with important roles in inflammation and cell death, in contrast, is activated by ADP-ribosylation. Here, we report the structural basis for this gating and present the first molecular model for the activation of a target protein by ADP-ribosylation. We demonstrate that the ecto-enzyme ART2.2 ADP-ribosylates P2X7 at arginine 125 in a prominent, cysteine-rich region at the interface of 2 receptor subunits. ADP-ribose shares an adenine-ribonucleotide moiety with ATP. Our results indicate that ADP-ribosylation of R125 positions this common chemical framework to fit into the nucleotide-binding site of P2X7 and thereby gates the channel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928361     DOI: 10.1096/fj.07-9294com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  Tightening of the ATP-binding sites induces the opening of P2X receptor channels.

Authors:  Ruotian Jiang; Antoine Taly; Damien Lemoine; Adeline Martz; Olivier Cunrath; Thomas Grutter
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

3.  Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.

Authors:  Shoji Notomi; Toshio Hisatomi; Takaaki Kanemaru; Atsunobu Takeda; Yasuhiro Ikeda; Hiroshi Enaida; Guido Kroemer; Tatsuro Ishibashi
Journal:  Am J Pathol       Date:  2011-10-08       Impact factor: 4.307

Review 4.  Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.

Authors:  Jin Wang; Ye Yu
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 5.  Orthosteric and allosteric binding sites of P2X receptors.

Authors:  R J Evans
Journal:  Eur Biophys J       Date:  2008-02-05       Impact factor: 1.733

Review 6.  Inhibition of P2X(7) receptors by divalent cations: old action and new insight.

Authors:  Lin-Hua Jiang
Journal:  Eur Biophys J       Date:  2008-04-15       Impact factor: 1.733

Review 7.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

8.  Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Authors:  Sahil Adriouch; Felix Scheuplein; Robert Bähring; Michel Seman; Olivier Boyer; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Purinergic Signal       Date:  2009-02-21       Impact factor: 3.765

Review 9.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

Review 10.  P2X receptors: dawn of the post-structure era.

Authors:  Mark T Young
Journal:  Trends Biochem Sci       Date:  2009-10-15       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.